AD5-CD/TKrep, an adenovirus expressing a cytosine deaminase/thymidine kinase (CD/TK) fusion protein that locally activates 5-fluorocytosine and ganciclovir pro-drugs, has been evaluated in two phase I clinical trials in patients with prostate cancer (9, 57). Here, CTLA4 is linked to prostate carcinoma.